Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
114,408,516
-
Share change
-
+6,704,264
-
Total reported value
-
$565,681,944
-
Put/Call ratio
-
53%
-
Price per share
-
$4.95
-
Number of holders
-
157
-
Value change
-
+$2,884,295
-
Number of buys
-
77
-
Number of sells
-
76
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2015
As of 30 Jun 2015,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,408,516 shares.
The largest 10 holders included
FMR LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, SAMLYN CAPITAL, LLC, Partner Fund Management, L.P., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Foresite Capital Management II, LLC, and CREDIT SUISSE AG/.
This page lists
157
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.